1. Home
  2. RGCO vs INBX Comparison

RGCO vs INBX Comparison

Compare RGCO & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGCO
  • INBX
  • Stock Information
  • Founded
  • RGCO 1912
  • INBX 2010
  • Country
  • RGCO United States
  • INBX United States
  • Employees
  • RGCO N/A
  • INBX N/A
  • Industry
  • RGCO Oil & Gas Production
  • INBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RGCO Utilities
  • INBX Health Care
  • Exchange
  • RGCO Nasdaq
  • INBX Nasdaq
  • Market Cap
  • RGCO N/A
  • INBX 198.2M
  • IPO Year
  • RGCO N/A
  • INBX 2020
  • Fundamental
  • Price
  • RGCO $20.36
  • INBX $15.06
  • Analyst Decision
  • RGCO
  • INBX Hold
  • Analyst Count
  • RGCO 0
  • INBX 1
  • Target Price
  • RGCO N/A
  • INBX N/A
  • AVG Volume (30 Days)
  • RGCO 10.7K
  • INBX 89.9K
  • Earning Date
  • RGCO 04-30-2025
  • INBX 05-08-2025
  • Dividend Yield
  • RGCO 4.07%
  • INBX 6.25%
  • EPS Growth
  • RGCO N/A
  • INBX N/A
  • EPS
  • RGCO 1.17
  • INBX 119.38
  • Revenue
  • RGCO $87,511,366.00
  • INBX $1,568,000.00
  • Revenue This Year
  • RGCO $7.25
  • INBX N/A
  • Revenue Next Year
  • RGCO $5.62
  • INBX N/A
  • P/E Ratio
  • RGCO $17.21
  • INBX $0.11
  • Revenue Growth
  • RGCO N/A
  • INBX 19.24
  • 52 Week Low
  • RGCO $18.38
  • INBX $10.80
  • 52 Week High
  • RGCO $24.20
  • INBX $18.95
  • Technical
  • Relative Strength Index (RSI)
  • RGCO 50.54
  • INBX 64.32
  • Support Level
  • RGCO $19.97
  • INBX $12.30
  • Resistance Level
  • RGCO $20.94
  • INBX $13.85
  • Average True Range (ATR)
  • RGCO 0.59
  • INBX 0.95
  • MACD
  • RGCO 0.02
  • INBX 0.17
  • Stochastic Oscillator
  • RGCO 67.36
  • INBX 92.57

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: